-
Symbol
-
VTGN on Nasdaq
-
Investment type
-
Equity / Common Stock, par value $0.001 per share
-
Latest Disclosed Shares Owned
-
1,824,738 shares
-
Security Ownership %
-
4.6%
Shares, Excluding Options vs Price
The Vanguard Group ownership in Vistagen Therapeutics, Inc. Common Stock, par value $0.001 per share (VTGN)
30 Jan 2026 - The Vanguard Group has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 1,824,738 shares of Vistagen Therapeutics, Inc. Common Stock, par value $0.001 per share (VTGN).
This represents 4.6% ownership of the company.
In their previous filing dated 31 Oct 2025, VANGUARD GROUP INC had reported owning 1,687,735 shares, indicating an increase of +8.1%.
.
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.